Trial · NCT01011556
Results by group404
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 404
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at 12 Months | 20 Mcg Subcutaneous Teriparatide | 7.80 | 90% Confidence Interval 6.867 to 8.730 | percentage change in BMD | |
| Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at 12 Months | 30 Mcg Transdermal Teriparatide | 0.63 | 90% Confidence Interval -0.321 to 1.578 | percentage change in BMD | |
| Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at 12 Months | 50 Mcg Transdermal Teriparatide | 0.32 | 90% Confidence Interval -0.657 to 1.287 | percentage change in BMD | |
| Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at 12 Months | 80 Mcg Transdermal Teriparatide | 1.63 | 90% Confidence Interval 0.739 to 2.519 | percentage change in BMD | |
| Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at 6 Months | 20 Mcg Subcutaneous Teriparatide | 4.74 | 90% Confidence Interval 3.953 to 5.537 | percentage change in BMD | |
| Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at 6 Months | 30 Mcg Transdermal Teriparatide | 0.16 | 90% Confidence Interval -0.661 to 0.983 | percentage change in BMD | |
| Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at 6 Months | 50 Mcg Transdermal Teriparatide | 0.88 | 90% Confidence Interval 0.051 to 1.705 | percentage change in BMD | |
| Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at 6 Months | 80 Mcg Transdermal Teriparatide | 1.19 | 90% Confidence Interval 0.418 to 1.957 | percentage change in BMD | |
| Time Course Change of BMD Response at the Lumbar Spine | 20 Mcg Subcutaneous Teriparatide | 6 months (n=54, 52, 51, 58) | 4.72 | 90% Confidence Interval 3.927 to 5.516 | percentage change in BMD |
| Time Course Change of BMD Response at the Lumbar Spine | 30 Mcg Transdermal Teriparatide | 6 months (n=54, 52, 51, 58) | 0.19 | 90% Confidence Interval -0.630 to 1.019 | percentage change in BMD |
| Time Course Change of BMD Response at the Lumbar Spine | 50 Mcg Transdermal Teriparatide | 6 months (n=54, 52, 51, 58) | 0.78 | 90% Confidence Interval -0.050 to 1.606 | percentage change in BMD |
| Time Course Change of BMD Response at the Lumbar Spine | 80 Mcg Transdermal Teriparatide | 6 months (n=54, 52, 51, 58) | 1.19 | 90% Confidence Interval 0.421 to 1.965 | percentage change in BMD |
| Time Course Change of BMD Response at the Lumbar Spine | 20 Mcg Subcutaneous Teriparatide | 12 months (n=52, 48, 45, 50) | 8.12 | 90% Confidence Interval 7.181 to 9.060 | percentage change in BMD |
| Time Course Change of BMD Response at the Lumbar Spine | 30 Mcg Transdermal Teriparatide | 12 months (n=52, 48, 45, 50) | 0.62 | 90% Confidence Interval -0.367 to 1.601 | percentage change in BMD |
| Time Course Change of BMD Response at the Lumbar Spine | 50 Mcg Transdermal Teriparatide | 12 months (n=52, 48, 45, 50) | 0.66 | 90% Confidence Interval -0.348 to 1.663 | percentage change in BMD |
| Time Course Change of BMD Response at the Lumbar Spine | 80 Mcg Transdermal Teriparatide | 12 months (n=52, 48, 45, 50) | 1.93 | 90% Confidence Interval 0.989 to 2.881 | percentage change in BMD |
| Percent Change From Baseline in Procollagen Type 1 N-Terminal Propeptide (P1NP) | 20 Mcg Subcutaneous Teriparatide | 1 month (n=49, 53, 49, 60) | 112.47 | Standard Deviation 65.390 | percentage change in P1NP |
| Percent Change From Baseline in Procollagen Type 1 N-Terminal Propeptide (P1NP) | 30 Mcg Transdermal Teriparatide | 1 month (n=49, 53, 49, 60) | 19.29 | Standard Deviation 35.274 | percentage change in P1NP |
| Percent Change From Baseline in Procollagen Type 1 N-Terminal Propeptide (P1NP) | 50 Mcg Transdermal Teriparatide | 1 month (n=49, 53, 49, 60) | 27.78 | Standard Deviation 31.064 | percentage change in P1NP |
| Percent Change From Baseline in Procollagen Type 1 N-Terminal Propeptide (P1NP) | 80 Mcg Transdermal Teriparatide | 1 month (n=49, 53, 49, 60) | 42.06 | Standard Deviation 53.000 | percentage change in P1NP |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01011556/results